Countries & territories / Lesser Antilles
Guadeloupe
Guadeloupe as a clinical research destination — the health system, the case for running studies here, and how PCRA Caribbean connects you to sites on the ground.
- Capital
- Basse-Terre
- Main languages
- French; Guadeloupean Creole widely spoken
- Currency
- Euro (EUR)
- Population
- ~380,000
Healthcare in Guadeloupe
Guadeloupe is part of France, and healthcare is delivered within the French health system - public hospitals and community practice funded through French social security, operating under European regulatory frameworks. For sponsors, that can mean an EU-framework option inside the Caribbean. The territory is served by university-hospital-level facilities alongside community care.
Why Guadeloupe for clinical research
The chronic-disease burden that dominates Caribbean healthcare - obesity, type 2 diabetes and hypertension - is a daily clinical reality in Guadeloupe, and most patients here have never been offered a place in a clinical study. For sponsors, that combination - genuine disease burden, largely research-naive patients, and concentrated care pathways - is exactly what makes the region worth a serious look. PCRA Caribbean is building its member-site network in Guadeloupe now: sites join by choice, are onboarded to a common ICH-GCP standard, and are matched only to studies they can genuinely deliver.
Member sites in Guadeloupe
Our anonymised directory shows the network's research-ready sites — sponsors can register for full site details, including which countries and territories each site serves.
Browse member sitesPlanning a study in Guadeloupe?
Tell us what your protocol needs and we'll give you an honest feasibility read — and if you run a hospital, clinic, pharmacy, lab or research unit in Guadeloupe, we'd love to hear from you too.